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ABSTRACT 
Manganese, an essential trace element, functions as an enzyme activator and is a constituent of several enzymes. 
Primary  signs  of  manganese  deficiency  are  impaired  growth,  skeletal  abnormalities,  depressed  reproductive 
function, ataxia of the newborn and faults in lipid and carbohydrate metabolism. Manganous oxide is a safe 
source of manganese for all animal species/categories, provided that the current maximum total contents of 
manganese authorised in feed are respected. Dietary manganese does not appear to cause any adverse effects in 
consumers at usual intake levels; manganese intake resulting from the consumption of tissues and products of 
animal origin  is low compared  with the intake resulting  from the consumption of  food of plant origin.  No 
essential differences in the manganese deposition in edible tissues and products of animal origin are expected 
from the use of manganous oxide compared with other inorganic manganese sources. The use of manganous 
oxide in animal nutrition is of no concern for the safety of consumers, provided that the current maximum total 
contents of manganese authorised in feed are respected. Handling manganous oxide is hazardous by inhalation to 
the user/worker; in the absence of adequate data, the additive should be considered as a potential skin and eye 
irritant and as a dermal sensitiser. The use of manganous oxide in animal nutrition for all animal species is not of 
concern for the environment, provided that the current maximum total contents of manganese authorised in feed 
are respected. Manganous oxide is an efficacious source of manganese in meeting the animal requirements. 
© European Food Safety Authority, 2013 
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SUMMARY 
Following  a  request  from  the  European  Commission,  the  Panel  on  Additives  and  Products  or 
Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the safety and 
efficacy of manganous oxide as feed additive for all animal species. 
Manganese, an essential trace element, functions as an enzyme activator and is a constituent of several 
enzymes (e.g. glycosyl transferases, pyruvate carboxylase, manganese superoxide dismutase). Primary 
signs of manganese deficiency are impaired growth, skeletal abnormalities, depressed reproductive 
function, ataxia of the newborn and faults in lipid and carbohydrate metabolism. 
Manganous  oxide  is  considered  safe  for  all  animal  species/categories,  provided  that  the  current 
maximum total contents of manganese authorised in feed are respected, that is, 100 mg/kg complete 
feedingstuffs for fish and 150 mg/kg for other species. 
Dietary manganese does not appear to cause any adverse effects in consumers at usual intake levels. 
Manganese intake resulting from the consumption of tissues and products of animal origin is low 
compared  with  the  intake  resulting  from  the  consumption  of  food  of  plant  origin.  No  essential 
differences in the manganese deposition in edible tissues and products of animal origin are expected 
from the use of manganous oxide compared with other inorganic manganese sources. The use of 
manganous oxide in animal nutrition is of no concern for the safety of consumers, provided that the 
current maximum total contents of manganese authorised in feed are respected. 
Handling manganous oxide is hazardous by inhalation to the user/worker. In the absence of adequate 
data, the additive should be considered as a potential skin and eye irritant and as a dermal sensitiser. 
The use of manganous oxide in animal nutrition for all animal species is not of concern for the 
environment, provided that the current maximum total contents of manganese authorised in feed are 
respected. 
Manganous oxide is an efficacious source of manganese in meeting the animal requirements. 
The FEEDAP Panel made recommendations concerning the description and conditions of use of the 
additive in the registry entry. Manganous oxide for all animal species 
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BACKGROUND 
Regulation  (EC)  No  1831/2003
1  establishes the rules governing the Community authorisation of 
additives for use in animal nutrition. In particular,  Article 10(2) of that Regulation also specifies that 
for existing products within the meaning of Article 10(1), an application shall be submitted in 
accordance with Article 7, at the latest one year before the expiry date of the authorisation given 
pursuant to Directive 70/524/EEC for additives with a limited authorisation p eriod, and within a 
maximum of seven years after the entry into force of this Regulation for additives authorised without a 
time limit or pursuant to Directive 82/471/EEC. 
The European Commission received a request from Poortershaven Industriële Mineralen B.V
2 for re-
evaluation of authorisation of the manganese -containing additive manganous oxide when used as a 
feed additive for all animal species (category: Nutritional additives; functional group: compounds of 
trace elements) under the conditions mentioned in Table 1.  
According  to  Article  7(1)  of  Regulation  (EC)  No  1831/2003,  the  Commission  forwarded  the 
application to the European Food Safety Authority (EFSA) as an application under Article 10(2) (re-
evaluation of an authorised feed additive). EFSA received directly from the applicant the technical 
dossier in support of this application.
3 According to Article 8 of that Regulation, EFSA, after verifying 
the particulars and documents submitted by the applicant, shall undertake an assessment in order to 
determine whether the feed additive complies with the conditions laid down in Article 5. The 
particulars and documents in support of the application were considered valid by EFSA as of  30 May 
2012. 
The additive “Manganous oxide” had been authorised in the European Union (EU) under the element 
Manganese-Mn  for  all  animal  species  “Without  a  time  limit”  (Commission  Regulation  (EC)  No 
1334/2003
4  and  amendments,  and  Commission  Regulation  (EC)  No  479/2006) .
5  Following  the 
provisions of Article 10(1) of Regulation (EC) No 1831/2003 the compounds were included in the EU 
Register of Feed Additives   under  the  category  “Nutritional  additives”  and  the  functional  group 
“Compounds of trace elements”.
6 
The  Scientific  Committee  on  Animal  Nutrition  (SCAN)  issued  a  report  on  the  use  of 
manganomanganic oxide in feedingstuffs (EC, 2002a). EFSA issued an opinion on the safety of the 
chelated forms of iron, copper, manganese and zinc with synthetic feed grade glycine (EFSA, 2005), 
and three opinions on a manganese chelate of hydroxy analogue of methionine (EFSA, 2008a, 2009, 
2010). 
TERMS OF REFERENCE  
According to Article 8 of Regulation (EC) No 1831/2003, EFSA shall determine whether the feed 
additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on the 
safety for the target animals, consumer, user and the environment and the efficacy of the Manganous 
oxide, when used under the conditions described in Table 1. 
                                                       
1   Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use 
in animal nutrition. OJ L 268, 18.10.2003, p. 29. 
2   Poortershaven Industriële Mineralen, B.V. Wijnhaven 84, 3011 WT, Rotterdam, The Netherlands. 
3   EFSA Dossier reference: FAD-2010-0235. 
4  Commission Regulation (EC) No 1334/2003 of 25 July 2003 amending the conditions for authorisation of a number of 
  additives in feedingstuffs belonging to the group of trace elements. OJ L 187, 26.7.2003, p. 11. 
5  Commission  Regulation  (EC)  No  479/2006  of  23  March  2006  as  regards  the  authorisation   of  certain  additives 
  belonging to the group compounds of trace elements. OJ L 86, 24.3.2006, p. 4. 
6  European  Union  Register  of  Feed  Additives  pursuant  to  Regulati on  (EC)  No  1831/2003 .  Available  online: 
http://ec.europa.eu/food/food/animalnutrition/feedadditives/comm_register_feed_additives_1831-03.pdf Manganous oxide for all animal species 
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Table 1:   Description and conditions of use of the additive as proposed by the applicant  
Additive   Manganous oxide 
Registration number/EC 
No/No (if appropriate) 
E5 
Category(-ies) of additive 
3. Nutritional  additives 
Functional group(s) of additive 
(b)Compounds of trace elements  
 
Description 
Composition, description  Chemical 
formula 
Purity criteria 
(if appropriate) 
Method of analysis 
(if appropriate) 
Manganous oxide  MnO    EN 15510:2007 
 
Trade name (if appropriate)   
Name of the holder of 
authorisation (if appropriate)   
 
Conditions of use 
Species  or 
category  of 
animal 
Maximum 
Age 
Minimum content  Maximum content  Withdrawal 
period 
(if 
appropriate) 
mg/kg of complete feedingstuffs 
Fish 
 
Other species 
-  - 
100 ppm 
 
150 ppm 
- 
 
Other provisions and additional requirements for the labeling 
Specific conditions or restrictions for 
use (if appropriate)  - 
Specific conditions or restrictions for 
handling (if appropriate)  - 
Post-market monitoring  
(if appropriate)  - 
Specific conditions for use in 
complementary feedingstuffs  
(if appropriate) 
- 
 
Maximum Residue Limit (MRL) (if appropriate) 
Marker residue  Species or category of 
animal 
Target tissue(s) or 
food products 
Maximum content in 
tissues 
-  -  -  - Manganous oxide for all animal species 
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ASSESSMENT 
This  opinion  is  based  in  part  on  data  provided  by  a  single  company  involved  in  the 
production/distribution  of  manganous  oxide.  It  should  be  recognised  that  this  data  covers  only  a 
fraction of the manganous oxide available on the market. The FEEDAP Panel has sought to use the 
data provided together with data from other sources to deliver an opinion. 
1.  Introduction  
Manganese (Mn) is an abundant element which makes up about 0.1 % of the Earth’s crust. It exists in 
a variety of oxidation states, Mn
2+ and Mn
3+ being the most biologically important. Although the 
elemental (metal) form of manganese does not occur naturally in the environment, manganese is a 
component of over 100 minerals (ATSDR, 2012).  
Manganese is an essential nutrient in humans and animals that plays a role in bone mineralization, 
protein and energy metabolism, metabolic regulation, cellular protection from damaging free radical 
species and formation of glycosaminoglycans (Wedler, 1994).  Manganese acts as both a constituent 
of  metalloenzymes  and  an  enzyme  activator.  Enzymes  that  contain  manganese  include  arginase, 
pyruvate carboxylase and manganese-superoxide dismutase (NRC, 1989; Keen and Zidenberg-Cher, 
1990; Wedler, 1994). Manganese, in its activating capacity, can bind either to a substrate (such as 
adenosine triphosphate, ATP), or to a protein directly, thereby causing conformational changes (Keen 
and Zidenberg-Cher, 1990). Manganese has been shown to activate numerous enzymes involved with 
either a catalytic or regulatory function (e.g. transferases, decarboxylases, hydrolases) (Wedler, 1994).  
The application is sought for the use of manganous oxide in feed for all animal species/categories.  
This manganese compound is already authorised in the EU as nutritional additive. 
A compilation of risk assessments carried out on manganese and its compounds, including opinions 
from  EFSA’s  panels  other  than  the  FEEDAP  Panel,  can  be  found  in  Appendix  B.  A  list  of 
authorisations  of  manganese  compounds  in  the  EU,  other  than  as  feed  additive,  is  reported  in 
Appendix C. 
EFSA commissioned the University of Gent (Belgium) to carry out a study of selected trace and 
ultratrace  elements  in  animal  nutrition,  including  manganese. The findings  were  submitted to  the 
EFSA in the form of a technical report (Van Paemel et al., 2010). Information from this report has 
been used in this opinion.  
2.  Manganous oxide 
For compounds of trace elements, the element itself is considered the active substance. 
2.1.  Characterisation and identity  
Manganous oxide (Chemical Abstracts Service (CAS) No 1344-43-0; International Union of Pure and 
Applied Chemistry (IUPAC) name: Manganese(II) oxide) has a molecular weight of 70.94 Da. Its 
molecular formula is MnO. The theoretical content of manganese is 77.4 %. Analysis of five batches 
revealed a manganese content of 77.077.1 %. However, the applicant reports as typical value 60 % 
manganese.
7 
2.1.1.  Impurities 
Four batches showed contents of 5.6–70.9 mg lead, 0.1–0.35 mg cadmium, 0.1–0.2 mg mercury and 
0.2–36.2 mg arsenic per kg of additive; three batches showed a content of 37–138 mg fluorine/kg 
                                                       
7 Technical Dossier/Section II/Annex 2.1.3.a.  Manganous oxide for all animal species 
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additive.
8 All values comply with Directive 2002/32/EC.
9 Dioxins and the sum of dioxins and dioxin-
like polychlorinated biphenyls (PCBs) were analysed over a period of four years (seven batches) 
showing values of < 0.1 ng PCDD/F-WHO-TEQ/kg and  < 0.13 ng PCDD/F-BCP-WHO-TEQ/kg, 
respectively.
10  Analysis of five batches showed a  nickel  content between 60 and 74 mg/kg ; the 
applicant stated that nickel is routinely analysed during manufacturing.
11 
2.1.2.  Physical properties 
The product is a solid, green crystalline powder. It is insoluble in water. Its density is 3.12 g/cm³ and 
its bulk density is 1.33 g/cm³. The particle shape is spherical to flake. In an average of five batches, the 
fraction of particles below 50 µm amounted to 62 % (w/w).  Dusting potential of three batches ranged 
between 7.3 and 10.8 g/m³.
12 Particle size analysis of the dust showed that 60 % (one batch) and 100 % 
(two batches) of the particles belonged to the respirable fraction (< 10 µm).
13 
2.1.3.  Manufacturing process 
Manganese dioxide and concentrated  manganese are the starting materials together with charcoal. 
Manganese materials are heated; the manganese is converted to manganous oxide by calcination and 
subsequently cooled. It is further milled and homogenised. The material safety data sheets of the raw 
materials
14 and of the final additive
15 are attached to the dossier. 
2.2.  Stability and homogeneity  
Stability of inorganic compounds of trace elements needs not be demonstrated. 
The potential homogeneous distribution of the additive was predicted  using a statistical approach  
(Jansen, 1992) in the case of a feed for chickens for fattening. The coefficient of variation was less 
than  1 %.
16  However, the FEEDAP Panel notes that th is method has been develop ed  to  test  the 
working  accuracy of  mixing  equipment  and its applicability to test homoge neity has not been 
demonstrated. The results are therefore not applicable to demonstrate the homogeneous distribution of 
an additive in feed. 
2.3.  Physico-chemical incompatibilities in feed 
Based on current knowledge, no incompatibilities resulting from the use of manganese in compound 
feed  are  expected,  other  than  those  widely  known  and  considered  by  feed  manufacturers  when 
formulating diets. 
2.4.  Conditions of use 
Manganous  oxide  is  intended  for  use  in  feed  of  all  animal  species  and  categories  without  time 
restrictions and up to a level of 100 mg/kg for fish and 150 mg/kg for other species. These levels are in 
accordance with the current authorisation. 
                                                       
8  Technical Dossier/Section II/Annex 2.1.4.a.  
9  Directive 2002/32/EC of the European Parliament and of the Council of 7 May 2002 on undesirable substances in 
  animal feed. OJ L 140, 30.5.2002, p. 10. 
10   Technical Dossier/Section II/Annex 2.1.4.b. 
11   Technical Dossier/Supplementary Information/Annex i. 
12   Technical Dossier/Supplementary Information/Annex ii. 
13   Technical Dossier/Supplementary Information/Annex v.1. 
14   Technical Dossier/Supplementary Information. 
15   Technical Dossier/Section II/Annex 2.5.2.a. 
16   Technical Dossier/Section II. Manganous oxide for all animal species 
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2.5.  Evaluation of the analytical methods by the  European Union Reference Laboratory 
(EURL) 
EFSA has verified the EURL report as it relates to the methods used for the control of manganese (six 
compounds, including manganous oxide) in animal feed. The Executive Summary of the EURL report 
can be found in Appendix A. 
3.  Safety 
3.1.  Safety for the target species  
Tolerance studies are not required for compounds of trace elements already authorised (Regulation 
(EC) No 429/2008).
17 The assessment of manganese safety for the target species is based on a previous 
opinion of the Scientific Committee on Food (EC, 2000) and on more recent FEEDAP Panel opinions 
(2009, 2010). 
Manganese is an essential trace element in livestock nutrition. Its essentiality in livestock nutrition 
(poultry) became evident in the 1930s (Lyons and Insko, 1937; Wilgus et al., 1937; Schaible et al., 
1938). 
Manganese has a long history of safe use. In general, manganese is considered to be one of the least 
toxic essential trace elements for farm animals. Depressed iron status and haematological changes are 
the most common signs of manganese toxicosis, also observed in animals fed adequate levels of iron 
(NRC, 2005). The National Research Council defined in 2005 maximum tolerable levels (MTLs, in 
mg/kg dry matter (DM)) for ruminants and poultry (2000), pigs (1000) and horses (400), whereas no 
MTL could be derived for fish because of insufficient data (NRC, 2005). The current authorised 
maximum total content in complete feed in the EU (100 mg/kg for fish and 150 mg/kg for other 
animal species) provides a sufficient margin of safety to the MTLs as well as a sufficient margin of 
safety to the allowances, with estimated requirements for chicken and turkeys for fattening of 60 
mg/kg, for laying hens of 30 mg/kg, for pigs and cattle of 1525 mg/kg (GfE, 1999, 2001, 2008; NRC, 
1994, 1998, 2001; Suttle, 2010). 
Since the additive contains nickel as a contaminant, the FEEDAP Panel assessed the impact of nickel 
on safety for the target species. Considering the background levels in animal feed as 500–4000 µg/kg 
DM  feed  (Nicholson  et  al.,  1999;  Van  Paemel  et  al.,  2010),  nickel  would  be  incorporated  by 
supplementing feeds with manganous oxide at extremely low quantities, that is ~10 μg Ni/kg fish feed 
(when adding 100 mg manganese from manganous oxide) and ~15 μg Ni/kg feed for other animal 
species/categories (when adding 150 mg manganese from manganous oxide). Therefore, no concerns 
for the safety of the target animals would arise from this particular aspect. 
3.1.1.  Interactions 
Manganese and iron compete for absorption sites. Fibre, phytate, calcium, phosphorus and magnesium 
may also interfere with manganese absorption. 
3.1.2.  Conclusion on the safety for species 
Manganous  oxide  is  considered  safe  for  all  animal  species/categories,  provided  that  the  current 
maximum total contents of manganese authorised in feed are respected, that is, 100 mg/kg complete 
feedingstuffs for fish and 150 mg/kg for other species. 
                                                       
17 Commission Regulation (EC) No 429/2008 of 25 April 2008 on detailed rules for the implementation of Regulation   (EC) 
No  1831/2003  of  the  European  Parliament  and  of  the  Council  as  regards  the  preparation  and  the  presentation  of 
  applications and the assessment and the authorisation of feed additives. OJ L 133, 22.5.2008, p. 1.  Manganous oxide for all animal species 
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3.2.  Safety for the consumer  
3.2.1.  Metabolic and residue studies 
Manganese is absorbed through the small intestine by non-saturable simple diffusion (Bell et al., 1989) 
or by a carrier-mediated transport mechanism with high affinity and low capacity (Garcia-Aranda et 
al., 1983). The absorption rate depends on the amount present in the gut. Typical apparent absorption 
may be in the range of 35 %, however, values as high as 40 % have been observed in veal calves with 
a supply of only 0.6 mg Mn/kg milk replacer (Kirchgessner and Neese, 1976) Absorption in poultry is 
lower, explaining the higher requirement. Intestinal absorption of manganese is also inversely related 
to iron intake (Lönnerdal, 1997). Manganese absorbed into portal circulation is transported by α2-
macroglobulins or albumin to the liver. The major portion of manganese in the liver is secreted into 
bile. Consequently manganese is primarily excreted via faeces. Urinary excretion of manganese is a 
minor route of excretion; it is of endogenous nature and therefore not related to the dietary intake 
(NRC, 2005). 
The highest concentrations of manganese are found in the liver, pancreas and kidney and the lowest 
levels occur in bone and fat. Nevertheless, manganese deposition in none of these tissues is considered 
a valuable indicator of manganese availability in the gut (Jongbloed et al., 2002). 
At  the request  of  EFSA, the  applicant  performed  a  literature  search  on  bioavailability  and  tissue 
deposition  from  manganous  oxide  in  comparison  with  other  inorganic  manganese  sources.
18  The 
databases used for this research were Web of Knowledge and those provided by Google Scholar. The 
keywords applied were reported. 
The applicant reported that literature on tissue/product deposition of manganese is less abundant than 
on some other minerals ,  and that  the most common  sources of manganese  as  feed additive are 
manganese oxide and manganese sulphate. Other inorganic sources of manganese such as manganous 
carbonate and manganous chloride are less abundant.  All publications found by the applicant are 
already considered in a review by Jongbloed et al. (2002) on the bioavailability of different manganese 
sources for pigs, poultry and ruminants. The following summary therefore refers only to this review. 
The relative bioavailability (RBV) of the  manganese from different manganese sources is given as a 
percentage of that for manganese sulphate (= 100). Endpoints used were mainly manganese deposition 
in bone for poultry, in kidney, liver and bone for ruminants, and absorption for pigs.  
In pigs, the RBV of manganese from manganous oxide was 95; that  of manganese from manganous 
carbonate was 96 (based on two experiments, supplemental manganese: 10 mg/kg).  
The RBVs in poultry (based on nine studies with supplemental dietary  manganese between 40 and 
2100 mg/kg) were 85 for manganese from manganous oxide (range 7799, n= 6), 97 for manganese 
from manganese chloride tetrahydrate (n= 1), 66 for manganese from manganese trioxide (n= 1) and 
31 for manganese from manganese dioxide (n= 1).  
For ruminants (sheep; seven experiments with supplemental dietary manganese between 900 and 4000 
mg/kg) the following RBVs were given: 91 for manganese from manganous oxide feed grade (n=1), 
80 for manganese from manganous oxide reagent grade (n= 1), 69 for manganese from manganous 
carbonate (range 6174, n= 2), and 67 for manganese from manganese dioxide (n= 1). 
Manganous  oxide  is  a  source  of  bioavailable  manganese  for  all  animal  species.  No  essential 
differences  in  the  manganese  deposition  in  edible  tissues  and  products  of  animal  origin  will  be 
expected from the use of manganous oxide compared with other inorganic manganese sources. 
                                                       
18   Technical Dossier/Supplementary Information. Manganous oxide for all animal species 
 
EFSA Journal 2013;11(8):3325  10 
3.2.2.  Toxicological profile of manganese 
Manganese is essential in the nutrition of both animals and humans. No toxicological studies were 
provided by the applicant. The FEEDAP Panel reviewed the relevant literature and considered several 
previous toxicological assessments of manganese. It is noted that there  are relatively limited data 
available on oral toxicity in laboratory animals and humans. 
3.2.2.1.  Toxicological reviews 
As is the case for all transition metals, long-term exposure to high doses of manganese poses a risk. 
The toxicology of manganese has been reviewed by the SCF (EC, 2000), the UK Expert Group on 
Vitamins and Minerals (EVM 2002, 2003), the US Environmental Protection Agency (EPA, 2003), 
the UK Institute of Environment and Health (IEH, 2007) and most recently the US Agency for Toxic 
Substances and Disease Registry (ATSDR, 2012). There is a consensus that the main toxic effects of 
manganese in humans concern the nervous system, the respiratory system (inhalatory exposure) and, 
to a lesser extent, the reproductive system. 
Chronic severe toxicity is primarily associated with effects on the central nervous system (CNS), 
especially through inhalation and long-term exposure, and is considered much more relevant than 
acute effects (Huang et al., 1989; cited by IEH, 2007). Common neurological symptoms arising from 
chronic manganism tend to occur in phases and start with anorexia, weakness and apathy, followed by 
a second phase of hallucinations, delusions and insomnia. During the later stages of chronic toxicity, 
Parkinson-like symptoms such as tremor and muscle rigidity take place. Although manganism and true 
idiopathic  Parkinson  disease  cause  very  similar  deficits  within  the  CNS,  they  differ  in  the 
neurotransmitters upon which they act; manganese toxicity results principally in the degeneration of 
GABAergic neurones in the globus pallidus whilst Parkinson disease is more associated with the 
dopaminergic neurons in the basal ganglia (Roth, 2006; cited by IEH, 2007).  
Manganese aggregates into non-haem iron regions of the brain such as the globus pallidus, substantia 
nigra  and  subthalamic  nuclei (Aschner  et  al.,  2007).  Although  the  precise  mechanisms  by  which 
manganese induces toxic effects within the CNS are a matter of continuing debate, there are a number 
of reports which highlight possible interactions between manganese and other trace elements such as 
iron, copper, and aluminium (IEH, 2007). Postulated mechanisms of manganese-induced neurotoxicity 
include (i) increased production of reactive oxygen species (Cohen, 1984; cited by IEH, 2007), (ii) 
neuronal degeneration by means of activation of glutamate-gated channels (Brouillet et al., 1993; cited 
by IEH, 2007), (iii) manganese in a divalent (or higher) oxidation state exerting toxicity on dopamine 
(Archibald and Tyree, 1987; cited by IEH, 2007), (iv) dopamine oxidation by manganese causing 
oxidative  DNA  damage  (Oikawa  et  al.,  2006,  cited  by  IEH,  2007)  and  (v)  production  of  6-
hydroxydopamine  (or  other  toxic  catecholamines;  Graham,  1984;  cited  by  IEH,  2007).  A  recent 
publication focuses on dopamine oxidation and mitochondrial damage as the main mode of action 
(Farina et al., 2013). 
There are association studies suggesting that, as in animal models, excess manganese exposure in 
humans  can  lead  to  reproductive  toxicity  resulting  in  decreased  fertility  and  increased  foetal 
abnormalities (Lauwerys et al., 1985; cited by IEH, 2007; Crossgrove and Zheng, 2004; cited by IEH, 
2007). For example, in one study manganese-exposed male workers were found to have fewer children 
than others (Lauwerys et al., 1985; cited by IEH, 2007). However, other studies did not find the same 
effect (IEH, 2007). 
The results of in vitro studies show that at least some chemical forms of manganese (manganous oxide 
not tested) have mutagenic potential (ATSDR, 2012). The issue of manganese genotoxicity has been 
recently  reconsidered  by  Lima  et  al.  (2011);  available  data  confirm  that  manganese  can  exert 
genotoxic effects in human lymphocytes ex vivo without any marked concurrent cytotoxicity. Likely 
mechanisms include oxidative damage (as a transition metal, manganese is a potential reactive oxygen 
species inducer) and the interaction with DNA polymerases and other proteins involved with DNA-
dependent processes (Wafik et al., 1984). The results of in vivo studies in rodents are inconsistent, and Manganous oxide for all animal species 
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in its assessment of manganese ATSDR (2012) was unable to draw an overall conclusion about the 
possible genotoxic hazard to humans from exposure to manganese compounds.  
Information on in vivo chronic toxicity of manganese comes from the National Toxicology program 
(NTP) which conducted two chronic studies in rats and mice (NTP, 1993). F344/N rats were exposed 
orally for two years to manganese from manganous sulphate at 60, 200 or 465 mg/kg body weight 
(bw) (males) or 70, 230 or 714 mg/kg bw (females). Under the conditions of this 2-year feeding study, 
there was no evidence of carcinogenic activity of manganese (II) sulphate monohydrate in male or 
female rats (NTP, 1993). In a 2-year study in B6C3F1 mice, the animals were exposed orally to 160, 
540 or 1800 mg Mn/kg bw (males) or 200, 700 or 2250 mg Mn/kg bw (females). There was equivocal 
evidence
19 of carcinogenic activity of manganese (II) sulphate monohydrate in male and female mice, 
based on a marginally increased incidence of thyroid gland follicular cell adenoma and a significantly 
increased incidence of follicular cell hyperplasia. The ingestion of diets containing manganese (II) 
sulphate monohydrate was associated with focal squamous hyperplasia of the forestomach in male and 
female mice, and ulcers and inflammation of the forestomach in male mice.  EVM (2002) echoed the 
conclusions by NTP (1993) and stated that “Chronic carcinogenicity studies of manganese sulphate in 
mice and rats were essentially negative, with equivocal evidence of carcinogenicity being observed in 
mice only”. There is no epidemiological or other evidence that manganese causes cancer in humans 
(ATSDR, 2012).  
As manganese is an essential element, oral exposure is not only unavoidable, but necessary to meet 
nutritional requirements. 
3.2.3.  Assessment of consumer safety 
Ingested manganese appears to be well tolerated in humans and manganese intake is generally low 
(mean  4.9  mg/day;  EVM,  2003).  The  general  population  is  exposed  to  manganese  through 
consumption  of  food  and  water,  inhalation  of  air  and  dermal  contact  with  air,  water,  soil,  and 
consumer products that contain manganese. The primary source of manganese intake is through the 
diet (ATSDR, 2012).  
Anaemic individuals may be vulnerable to the toxic effects of manganese as a result of the increased 
absorption that occurs in states of iron deficiency. Groups with impaired biliary clearance, such as 
patients with liver disease or elderly people, may also be susceptible to manganese accumulation and 
toxicity. It has also been reported that ethanol and long-term use of anti-psychotic drugs increases the 
susceptibility of humans to manganese toxicity (EVM, 2002). 
The SCF (EC, 2000) could not conclude about a tolerable upper intake level (UL) of manganese 
owing to significant data gaps. Correspondingly, the ATSDR (2012) could not establish oral Minimal 
Risk Levels for acute, intermediate, or chronic duration of oral exposure to manganese. However, a 
Tolerable Upper Intake Level for adults of 11 mg manganese/day has been set by the US Food and 
Nutrition Board of the Institute of Medicine (FNB/IOM, 2001) based on an estimate that people eating 
vegetarian or Western-style diets consume up to 10.9 mg Mn/day with no reports of adverse effects 
(Greger, 1999). No recommended dietary allowance has been defined for manganese. The FNB/IOM 
(2001) has set adequate intake (AI) levels for manganese for humans. The AIs are 2.3 and 1.8 mg/day 
for males and females, respectively, and 1.2 mg/day for toddlers. Based on the dietary intake plus 4 
mg/person perday from supplements, the EVM (2003) estimated a guidance value of 0.2 mg Mn/kg 
bw per day, corresponding to 12 mg/day for a 60-kg person. The guidance value for older people (60 
kg bw) is 0.15 mg/kg bw. 
The normal dietary intake is calculated to be approximately 2-5 mg/day (Jankovic, 2005; cited by IEH, 
2007). This is in line with older data reviewed by the SCF (EC, 2000) and the EVM (2003). The 
dietary intake of adults has been estimated to range from 0.9 to 7 mg Mn/day (Schlettwein-Gsell and 
                                                       
19   “Equivocal  evidence”  of  carcinogenic  activity  is  demonstrated  by  studies  that  are  interpreted  as  showing  a  marginal 
increase of neoplasms that may be chemical related (NTP, 1993).  Manganous oxide for all animal species 
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Mommsen-Straub, 1973; cited by EC, 2000), 2 to 9 mg Mn/day (WHO-IPCS, 1981; cited by EC, 
2000) and 1.2 to 9.4 mg Mn/day (Ellen et al., 1990; cited by EC, 2000). A Total Diet Study showed 
that the estimated average intake of manganese in the UK population in 1994 was 4.9 mg/day (97.5th 
percentile: 8.2 mg/day), including 2.3 mg/day from beverages (MAFF, 1997; cited by EC, 2000).  
According to EPA (2003) “Nuts and nut products contain between 18.2 and 46.8 mg Mn/kg, grain and 
grain products between 0.4 and 40.7 mg, legumes between 2.2 and 6.7 mg, fruits between 0.2 and 10.4 
mg, vegetables and vegetable products between 0.4 and 6.6 mg, meat (poultry, fish, eggs) between 0.1 
and 4.0 mg, milk and milk products between 0.02 and 0.49 mg Mn/kg”. The manganese content in food 
is in the same order of magnitude as those reported by Souci et al. (2008), who reported the following 
(values represent the range of averages for several animal species): milk, 0.025–0.068; muscle, 0.13–
0.38; heart, brain and kidney, 0.24–1.50; and liver, 2.80–3.30 mg/kg fresh matter. 
Manganese intake can be higher in vegetarians because higher levels of manganese occur in food of 
plant origin. Tea drinkers are a potential high-intake group (a cup of tea can contain 0.41.3 mg 
manganese (WHO, 1996; cited by EC, 2000; the manganese content of black tea is reported to be 730 
mg/kg dried tea (Souci et al., 2008)), although the bioavailability of manganese in tea is unclear and 
may be low owing to the presence of tannins. Many individuals who do not consume whole grains, 
nuts, certain fruits (pineapple), green leafy vegetables and tea will consume a “low-manganese” diet 
—less than 2 mg per day (Davis et al., 1992; cited by EPA, 2003).  
The SCF (EC, 2000) noted that the available data indicate that, in both humans and experimental 
animals, the margin between oral effect levels and the estimated intake from food is low, suggesting 
that oral exposure to manganese beyond that normally present in food and beverages could represent a 
risk of adverse health effects without evidence of any health benefit. 
Since supplementation of feed for food-producing animals has a long history of use, it is suggested 
that the intake data referred to above include food originating from animals reared with manganese-
supplemented feed. Manganous oxide and manganous sulphate are commonly used inorganic sources 
of manganese feed supplementation. The level of manganese intake resulting from the consumption of 
tissues and products of animal origin is not of concern for the safety of consumers, including more 
sensitive subgroups such as infants and elderly people. It is concluded that the use of manganous oxide 
in animal nutrition is of no concern for the safety of consumers. 
3.2.4.  Conclusions on safety for consumers 
Generally, dietary manganese does not appear to cause any unwanted health effects in the population 
and  has  not  proven  to  be  a  risk  at  usual  intake  levels.  Manganese  intake  resulting  from  the 
consumption of tissues and products of animal origin is low and is not of concern for the safety of 
consumers including more sensitive subgroups such as infants and elderly people. It is concluded that 
the use of manganous oxide in animal nutrition is of no concern for the safety of consumers, provided 
that the current maximum total contents of manganese authorised in feed are respected. 
3.3.  Safety for the user 
Manganese is a recognized workplace toxicant upon inhalation exposure. Inhalation of manganese 
results in pulmonary oedema and tracheobronchitis (Nemery, 1990; cited by IEH, 2007). Furthermore, 
inhaled manganese is particularly hazardous as it can be transported directly to the brain, bypassing 
the liver metabolism (ATSDR, 2012). Some studies suggest that manganese inhalation can result in 
adverse cognitive effects, such as attention deficit and amnesia (ATSDR, 2012). Individuals subject to 
prolonged occupational exposure to high levels of manganese are considered to be most at risk. Thus, 
welders, miners and other metal industry workers have exhibited increased incidences of pulmonary 
conditions such as pneumonia and bronchitis (Saric and Piasek, 2000; cited by IEH, 2007). The lung 
epithelium functions as a barrier to infection and its ability to respond to foreign antigens is disrupted 
in the presence of manganese along with many other transition metals. In a study by Roth and Garrick Manganous oxide for all animal species 
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(2003;  cited  by  IEH,  2007),  manganese  was  regarded  as  the  second  most  important  metal,  after 
copper, in causing inflammation of the lung tissue. This inflammation is thought to occur by means of 
cytokine release (interleukins) as opposed to being immunoglobulin (IgE) mediated.  
Up to 60 % of the particles of the additive are below the respirable size (10 µm) and the dusting 
potential  is  estimated  by  the  Stauber-Heubach  method  to  be  5.68.3  g  Mn/m
3.  Exposure  of 
workers/users by inhalation when handling the product is highly likely.  
The  Health  and  Safety  Executive  (HSE)  of  the  UK  and  the  Occupational  Safety  and  Health 
Administration  (OSHA) of the USA have set an occupational exposure standard (OES) for dust from 
manganese and its compounds (HSE, 2003; OSHA, 2007). The OES (8-hour time-weighted average) 
for dust is 5 mg Mn/m
3. Since the manganese concentration in the dust produced by manganese oxide 
in  the  Stauber-Heubach  apparatus  is  about  1100-1700  times  higher  than  the  OES,  handling  the 
additive is hazardous to users. 
In the absence of adequate data regarding irritancy to the skin and eyes and dermal sensitisation, the 
additive should be considered as a potential skin and eye irritant and as a dermal sensitiser.  
3.4.  Safety for the environment 
Manganese is the second most abundant (after iron) transition element in the Earth’s crust, with an 
estimated global average in soil of 437 mg/kg (Forum of European Geological Surveys, FOREGS).
20 
The median concentration of manganous oxide in 845 samples of topsoil collected throughout Europe 
for the FOREGS survey was 650 mg/kg and the manganese content of the acid soluble fraction (Aqua 
regia)  contained  382  mg/kg,  with  a  range  of  <  106480  mg  kg  (FOREGS).  The  behaviour  of 
manganese in soil is very complex and is controlled by different environmental factors, of which pH-
Eh conditions are the most important (Kabata-Pendias, 2001). Mn
2+ appears to have low affinity for 
organic ligands (Lazerte and Burling, 1990; Chiswell and Zaw, 1991). However, whilst the Mn
2+ 
(aqueous) ion is readily soluble, manganese in soil is not very mobile, because Mn
3+ and Mn
4+ form 
insoluble hydrous oxides, especially under oxidising conditions. 
Concentrations of dissolved manganese in European stream waters from the FOREGS survey range 
from < 0.05 to 698 μg/L, with a median value of 15.9 μg/L (n= 804). The lowest values of dissolved 
manganese (< 1.7 μg/L) are found in central and northern Sweden, in central and south Norway, and in 
western Scotland and western England on Caledonian terrains (FOREGS). 
3.4.1.  Environmental safety from use in feeds for terrestrial farm animals 
Based on the calculation method provided in the technical guidance for assessing the safety of feed 
additives for the environment  (EFSA, 2008b), the highest theoretical addition of manganese in soil 
(PECsoil) from animal feeds is around 3 mg/kg (lambs and chickens for fattening) after a 1- year 
application of manure assuming that 100 % of a dose will be excreted. As the median content of 
manganese  in  European  soil  is  over  two  orders  of  magnitude  higher  than  this  value,  the  use  of 
manganese in animal feeds at the legislated inclusion levels is not expected to pose a risk to the soil 
compartment.  
Following  the  technical  guidance  and further  assuming  that  manganous  oxide  will  be  completely 
dissociated in the gut and solubilised to Mn
2+, the predicted concentrations of manganese in surface 
water (PECsw) would range from 332 to 630 μg/L, with the highest concentrations resulting from the 
use  of  manganous  oxide  in  feed  for  lambs  and  chickens  for  fattening.  This  worst-case  scenario 
suggests that supplementation of animal feeds with manganous oxide would markedly increase the 
background  concentrations  of  manganese  in  surface  waters.  However,  this  outcome  is  considered 
unrealistic because the calculated worst-case PECsoil is much lower than background concentrations, 
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and it is likely that manganese added to the soil through the spreading of manure would oxidise to 
insoluble (III) and (IV) forms and otherwise would behave similarly to that naturally present. Thus, 
the  use  of  manganous  oxide  in  feeds  for  terrestrial  animals  up  to  a  concentration  of  150  mg/kg 
complete feed is considered safe to the aquatic compartment. 
3.4.2.  Environmental safety from use in aquaculture feeds 
Using  its  technical  guidance  (EFSA,  2008b)  the  FEEDAP  Panel  calculated  the  worst-case 
concentrations in the environment resulting from the supplementation of fish feeds with manganous 
oxide at the total level of 100 mg Mn/kg. When fed to fish in seacages, the sediment under the cage is 
considered the compartment of concern (EFSA, 2008b). The PECsed was calculated to be 212 μg/kg 
wet weight, which substantially exceeds the threshold for Phase I assessment (10 μg/kg). However, 
manganese concentrations in top sediment in marine and estuarine environments vary widely from 10 
to at least 4000 mg/kg, which in all cases far exceeds that maximally emitted from aquaculture (Sadiq 
and Zaidi, 1985; Cahill and Unger, 1993; Galasso et al., 2000; Sahli et al., 2011). For land-based 
aquaculture operations, such as ponds and raceways, the surface water downstream of the fish farm is 
considered the most sensitive compartment (EFSA, 2008b). The PECswaq was calculated to be 1.02.0 
μg/L,  depending  on  the  species.  This  concentration  exceeds  the  trigger  value  by  one  order  of 
magnitude, but is also one order of magnitude lower than the median concentration of manganese in 
European freshwaters (FOREGS).  
3.4.3.  Conclusions on safety for the environment 
The use of manganous oxide in animal nutrition for all animal species is not of concern for the 
environment, provided that the current maximum total contents of manganese authorised in feed are 
respected.  
4.  Efficacy 
According  to  Commission  Regulation  (EC)  No  429/2008,  no  efficacy  studies  are  required  for 
compounds of trace elements already authorised as feed additives.  
The use of manganous oxide as manganese source in animal nutrition is extensively documented in the 
scientific literature and summarised by McDowell (2003) and Suttle (2010). Manganous oxide is an 
efficacious source of manganese in meeting the animal requirements. 
5.  Post-market monitoring 
The  FEEDAP  Panel  considers  that  there  is  no  need  for  specific  requirements  for  a  post-market 
monitoring  plan  other  than  those  established  in  the  Feed  Hygiene  Regulation
21  and  Good 
Manufacturing Practice. 
CONCLUSIONS AND RECOMMENDATIONS 
CONCLUSIONS 
Manganous  oxide  is  considered  safe  for  all  animal  species/categories,  provided  that  the  current 
maximum total contents of manganese authorised in feed are respected, that is, 100 mg/kg complete 
feedingstuffs for fish and 150 mg/kg for other species. 
Dietary manganese does not appear to cause any adverse effects in consumers at usual intake levels. 
Manganese intake resulting from the consumption of tissues and products of animal origin is low 
compared  with  the  intake  resulting  from  the  consumption  of  food  of  plant  origin.  No  essential 
differences in the manganese deposition in edible tissues and products of animal origin are expected 
from the use of manganous oxide compared  with other inorganic manganese sources. The use of 
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manganous oxide in animal nutrition is of no concern for the safety of consumers, provided that the 
current maximum total contents of manganese authorised in feed are respected. 
Handling manganous oxide is hazardous by inhalation to the user/worker. In the absence of adequate 
data, the additive should be considered as a potential skin and eye irritant and as a dermal sensitiser. 
The use of manganous oxide in animal nutrition for all animal species is not of concern for the 
environment, provided that the current maximum total contents of manganese authorised in feed are 
respected. 
Manganous oxide is an efficacious source of manganese in meeting the animal requirements. 
RECOMMENDATIONS 
In  the  current  legislation  the  name  of  the  additive  is  ‘Manganous  oxide’.  The  FEEDAP  Panel 
recommends to follow the IUPAC nomenclature to avoid potential misunderstanding and to introduce 
the name ‘Manganese(II) oxide’. 
The Description and conditions of use of the additive as proposed by the applicant should be amended 
as follows:  
  The description of the additive should contain the minimum content of manganese, e.g. 75 % 
(according to the analytical values) 
  Other provisions should contain:  
 “The incorporation of the additive into feed should be made via premixtures only”, to ensure 
user safety. 
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APPENDICES 
APPENDIX A 
Executive Summary of the Evaluation Report of the European Union Reference Laboratory for 
Feed Additives on the Method(s) of Analysis for Manganese (E5)
1 
In the current application authorisation is sought under articles 4(1) and 10(2) for manganese chelate 
of glycine hydrate
2, manganese chelate of amino acids hydrate
2,3, manganous oxide
2,4,5, manganous 
carbonate
2,  manganous  chloride  tetrahydrate
2  and  manganous  sulfate  monohydrate
2,5  under  the 
category/ functional group (3b) "nutritional additives"/"compounds of trace elements", according to 
the classification system of Annex I of Regulation (EC) No 1831/2003. Specifically, authorisation is 
sought for the use of these feed additives for all categories and species. 
According to the Applicants manganese chelate of glycine hydrate is a beige to pink free-flowing 
powder with a minimum content of 20 % total manganese, manganese chelate of amino acids hydrate 
is a off-white to tan marbeled free-flowing powder with a minimum content of 10 % total manganese, 
manganous oxide is a red brown-green powder with a minimum content of 59.5 % total manganese, 
manganous  carbonate  is  a  beige  powder  with  a  minimum  content  of  44  %  total  manganese, 
manganous chloride tetrahydrate is a pink powder with a minimum content of 27 % total manganese 
and manganous sulfate monohydrate is a pink-grey crystalline powder with a minimum content of 31 
% total manganese. These feed additives are intended to be mixed into premixtures, feedingstuffs and 
water*. The Applicants suggested maximum levels ranging from 100 to 150 mg total manganese /kg 
feedingstuffs and from 15 to 75 mg total manganese /L water, similar to limits set in the previous 
regulations [4,5]. 
For  the  characterisation  of  manganous  sulfate  monohydrate  in  the  feed  additive  the  EURL 
recommends the titrimetric method described in the European Pharmacopoeia monograph 1543. 
For  the  quantification  of  “amino  acid”  content  in  the  amino  manganese  chelates (i.e.  manganese 
chelate of glycine hydrate and manganese chelate amino acids hydrate), the Applicant (FAD-2010-
0088) proposed the Community method based on ion exchange chromatography combined with post-
column  ninhydrin  derivatisation  and  photometric  detection  at  570  nm.  The  EURL  considers  the 
Community method suitable for the characterisation of the amino compounds in the frame of official 
control. 
Furthermore,  the  EURL  identified  the  generic  European  Pharmacopoeia  methods  for  the 
"identification reactions of ions and functional groups", such as carbonate, chloride and sulfate in the 
feed additives. Finally, the EURL recommends crystallographic techniques, such as X-Ray diffraction 
for  the  characterisation  of  crystalline  structures  of  manganous  oxide,  manganous  chloride 
tetrahydrate, manganous carbonate and manganous sulfate monohydrate. 
For the quantification of total manganese in the feed additives, premixtures and feedingstuffs the 
Applicants submitted three ring trial validated CEN methods: EN 6869, based on atomic absorption 
spectrometry (AAS), EN 15510, based on inductively coupled plasma atomic emission spectroscopy 
(ICP-AES) and CEN/TS 15621, based on ICP-AES after pressure digestion. Precisions ranging from 2 
to  20 %  were  reported,  together  with limits of  quantification  (LOQ)  ranging  from  1  to  5  mg/kg 
feedingstuffs.  Furthermore,  the  EURL  identified  the  comparative  trial  organised  by  the  UK  Food 
                                                       
1  The  full  report  is  available  on  the  EURL  website:  https://ec.europa.eu/jrc/sites/default/files/FinRep-SANCO-
Manganese.pdf  
2  FAD-2010-0088. 
3  FAD-2010-0069. 
4  FAD-2010-0166. 
5  FAD-2010-0235. Manganous oxide for all animal species 
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Standards  Agency,  based  on  the  Community  method  for  the  determination  of  manganese  in 
feedingstuffs, in which precisions ranging from 2.7 to 7.1 % were reported. 
For the quantification of total manganese in water the EURL identified the ring trial validated method 
EN  ISO  11885,  based  on  ICP-AES.  The  following  performance  characteristics  are  reported:  -  a 
relative standard deviation for repeatability (RSDr) ranging from 1.3 to 1.8 %; - a relative standard 
deviation for reproducibility (RSDR) ranging from 4.6 to 6.0 %; and LOQ = 1 μg/L. 
Based on the available performance characteristics the EURL recommends for official control all the 
above mentioned CEN methods together with the Community method to quantify total manganese 
content in the feed additives, premixtures, feedingstuffs and/or water. 
Further  testing  or  validation  of  the  methods to  be performed  through  the consortium  of  National 
Reference Laboratories as specified by Article 10 (Commission Regulation (EC) No 378/2005) is not 
considered necessary. 
 
 
 
 
(*)  for  manganese  chelate  of  glycine  hydrate,  manganous  chloride  tetrahydrate  and  manganous 
sulfate monohydrate (FAD-2010-0088). 
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APPENDIX B 
List of Risk Assessment Reports on manganese and manganese compounds  
Besides the reports cited in the Background section and in the text as references, risk assessments from 
other EU bodies and Institutions have been carried out.  
1.  EC Health and Consumers Scientific Committees Opinions 
Scientific Committee on Food. Opinion on arsenic, barium, fluoride, boron and manganese in natural 
mineral  waters  (Expressed  on  13  December  1996) 
(http://ec.europa.eu/food/fs/sc/oldcomm7/out09_en.html) 
2.  European and other countries Risk Assessment Reports 
Food  Standard  Agency  Risk  Assessment  Manganese 
(http://www.food.gov.uk/multimedia/pdfs/evm_manganese.pdf) 
Health Canada Agency – Human health risk assessment for inhaled manganese  
(http://www.hc-sc.gc.ca/ewh-semt/pubs/air/manganese-eng.php) 
3.  EFSA-ANS Panel Opinions 
Manganese  ascorbate,  manganese  aspartate,  manganese  bisglycinate  and  manganese  pidolate  as 
sources of manganese added for nutritional purposes to food supplements - Scientific Opinion of 
the  Panel  on  Food  Additives  and  Nutrient  Sources  added  to  Food  (ANS). 
(http://www.efsa.europa.eu/en/efsajournal/doc/1114.pdf) 
4.  EFSA-CEF Panel Opinions 
Scientific Report of EFSA on the risk assessment of salts of authorised acids, phenols or alcohols for 
use in food contact materials. (http://www.efsa.europa.eu/en/efsajournal/doc/1364.pdf). 
5.  EFSA-NDA Panel Opinions  
Scientific Report submitted to EFSA - Literature search and review related to specific preparatory 
work  in  the  establishment  of  Dietary  Reference  Values:  Preparation  of  an  evidence  report 
identifying health outcomes upon which Dietary Reference Values could potentially be based for 
chromium, manganese and molybdenum. (http://www.efsa.europa.eu/en/efsajournal/doc/1147.pdf) 
Scientific Opinion on the substantiation of health claims related to manganese and protection of DNA, 
proteins  and  lipids  from  oxidative  damage  (ID  309),  maintenance  of  bone  (ID  310),  energy-
yielding  metabolism  (ID  311),  and  cognitive  function  (ID  340)  pursuant  to  Article  13(1)  of 
Regulation (EC) No 1924/2006. (http://www.efsa.europa.eu/en/efsajournal/doc/1217.pdf) 
 
Scientific  Opinion  on  the  substantiation  of  health  claims  related  to  manganese  and  reduction  of 
tiredness and fatigue (ID 312), contribution to normal formation of connective tissue (ID 404) and 
contribution  to  normal  energy-yielding  metabolism  (ID  405)  pursuant  to  Article  13(1)  of 
Regulation (EC) No 1924/2006. (http://www.efsa.europa.eu/en/efsajournal/doc/1808.pdf) 
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APPENDIX C 
List of authorisations of manganese compounds other than feed additive 
The  following  manganese  compounds  are  authorised  for  use  in  food  (Regulation  (EC)  No 
1170/2009):
6  manganese  ascorbate,  manganese  L -aspartate,  manganese  bisglycinate,  manganese 
carbonate,  manganese  chloride,  manganese  citrate,  manganese  gluconate,  manganese 
glycerophosphate, manganese pidolate and manganese sulphate which may be used in the manufacture 
of food supplements; manganese carbonate, manganese chloride, manganese citrate, mang anese 
gluconate,  manganese  glycerophosphate  and  manganese  sulphate  which  may  be    used  in  the 
manufacture of  food supplements and may be added to food. 
The  following  manganese  compounds  can  be  used  for  the  manufacturing  of  dietetic  foods 
(Commission Regulation (EC) No 953/2009):
7 manganese carbonate, manganese chloride, manganese 
citrate, manganese gluconate, manganese glycerophosphate and manganese sulphate. 
The following manganese compounds can be used for the manufacturing of processed cereal -based 
foods  and  baby  foods  for  infants  and  young  children  (Commission  Directive  2006/125/EC):
8 
manganese carbonate, manganese chloride, manganese citrate, manganese gluconate, manganese 
glycerophosphate and manganese sulphate. 
Regarding pharmacologically active substances and their classification regarding maximum residue 
limits in foodstuffs of animal origin, the following manganese compounds are listed in Table 1 of the 
Annex of Regulation 37/2010
9  as  Allowed  substances,  no  MRL  required:  dimanganese  trioxide, 
manganese  carbonate,  manganese  chloride,  manganese  gluconate,  manganese  glycerophosphate, 
manganese oxide, manganese pidolate, manganese ribonucleate and manganese sulphate. According to 
article 14(7) of Regulation (EC) No 470/2009
10 these compounds are for oral use only.  
The following  manganese compound is listed in Annex of Commission Implementing Regulation 
(EU) No 540/2011
11 as “Active substances approved for use in plant protection products”: manganese 
ethylenebis  (dithiocarbamate,  polymeric)  (Maneb)  and  manganese  ethylenebis  (dithiocarbamate, 
polymeric) complex with zinc salt (Mancozeb). 
The following type of fertilisers for manganese as Fertilisers containing only one micro-nutrient are 
listed in Annex I of Regulation (EC) No 2003/2003
12 of the European Parliament and of the Council: 
(a) manganese salt (chemically obtained product containing a mineral manganese salt (Mn II) as its 
essential ingredient), (b) manganese chelate (water-soluble product obtained by combining manganese 
chemically with a chelating age nt),  (c)  manganese oxide (chemically obtained product containing 
manganese oxides as essential ingredients),   (d)  manganese-based fertiliser ( product obtained by 
                                                       
6  Commission Regulation (EC) No 1170/2009 of 30 November 2009 amending Directive 2002/46/EC of the European 
  Parliament and of Council and Regulation (EC) No 1925/2006 of the European Parliament and of the Council as regards 
  the lists of vitamin and minerals and their forms that can be added to foods, including food supplements. OJ L 314, 
  1.12.2009, p. 36. 
7  Commission Regulation (EC) No 953/2009 of 13 October 2009 on substances that may be added for specific nutritional 
  purposes in foods for particular nutritional uses. OJ L 269, 14.10.2009, p. 9. 
8  Commission Directive 2006/125/EC of 5 December 2006 on processed cereal-based foods and baby foods for infants and 
  young children. OJ L 339, 6.12.2006, p. 16. 
9  Commission Regulation (EU) No 37/2010 of 22 December 2009 on pharmacologically active  substances and their 
  classification regarding maximum residue limits in foodstuffs of animal origin. OJ L 15, 20.1.2010, p. 1 
10 Regulation (EC) no 470/2009 of the European Parliament and of the Council  of 6 May 2009 laying down Community 
procedures for the establishment of residue limits of pharmacologically active substances in foodstuffs of animal origin, 
repealing Council Regulation (EEC) No 2377/90 and amending Directive 2001/82/EC of the European Parliament and of 
the Council and Regulation (EC) No 726/2004 of the European Parliament and of the Council OJ L 152, 16.6.2009, p. 11. 
11 Commission Implementing Regulation (EU) No 540/2011 of 25 May 2011 implementing Regulation (EC) No 1107/2009 
of the European Parliament and of the Council as regards the list of approved active substances. OJ L 153, 11.6.2011, p. 1 
12 Regulation (EC) No 2003/2003 of the European Parliament and of the Council of 13 October 2003 relating to fertilisers. 
OJ L 304, 21.11.2003, p. 1. Manganous oxide for all animal species 
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mixing types (a) and (c)) and (e) manganese-based fertiliser solution (product obtained by dissolving 
types (a) and/or one of the type (b) in water). 
The  following  manganese  compounds  can  be  used  for  cosmetic  purposes  (Regulation  (EC)  No 
1223/2009 of the European Parliament and of the Council):
13 ammonium manganese (3+) diphosphate 
and trimanganese bis (orthophosphate). 
According to the Annex of Regulation (EC) No 432/201214 the following health claims can be made 
only for food which is at least a source of manganese as referred to in the claim SOURCE OF [NAME 
OF VITAMIN/S] AND/OR [NAME OF MINERAL/S] as listed in the Annex to Regulation (EC) No 
1924/200615: manganese contributes to normal energy-yielding metabolism, manganese contributes to 
the maintenance of normal bones, manganese contributes to the normal formation of connective tissue 
and manganese contributes to the protection of cells from oxidative stress. 
  
 
                                                       
13   Regulation  (EC)  No  1223/2009  of  the  European  Parliament  and  of  the  Council  of  30  November  2009  on  cosmetic 
products. OJ L 342, 22.12.2009, p. 59. 
14 Commission Regulation (EC) No 432/2012 of 16 May 2012  establishing a list of permitted health claims made on foods, 
other than those referring to the reduction of disease risk and to children’s development and health. OJ L 136, 25.05.2012, 
p.1. 
15   Regulation (EC) No 1924/2006 of the  European Parliament and of the council of 20 December 2006  on nutrition and 
health claims made for food. OJ L 404, 30.12.2006, p.9. 
 